Oncologist, scientist, teacher & learner
Pasadena, CA
Joined May 2016
- Tweets213
- Following443
- Followers432
- Likes124
Jorge Nieva retweeted
Grateful to have contributed to this important collaborative study with Dr. Jaclyn LoPiccolo and an incredible research team.
Together, we explored the genetic factors that may shape risk and tumor biology in young-onset lung cancer.
Swipe through for the key findings. 🧬🫁
pmc.ncbi.nlm.nih.gov/article…
Jorge Nieva retweeted
Thank you to @nievamd @uscnorris for sharing insights into fascinating #AACR26 data.
Could residue from pesticides be driving the 'hidden' #LungCancer epidemic among young nonsmokers?
Find out here 👇
🍓🥬 ‘Counterintuitive’ data from #AACR26 suggests higher consumption of fruit, vegetables & whole grains may raise #LungCancer risk among younger nonsmokers.
❗ Exposure to #pesticide residue could be to blame. vist.ly/4zihh
Jorge Nieva retweeted
First-line #NSCLC care has evolved. In a conversation with @ADesaiMD (@ONealCancerUAB), @nievamd (@uscnorris) explains how patient priorities shape treatment intensification: bit.ly/4aTBGuG
#NSCLC #CancerCare
Jorge Nieva retweeted
🫁 As Lung Cancer Awareness Month continues, don't miss this insightful interview with @nievamd of @KeckMedicineUSC, who reflects on the importance of #LCAM, the cultural shift he's seen around lung cancer, and why screening is critical.
➡️ Watch: buff.ly/BsXjTto
#lcsm
Jorge Nieva retweeted
💊 How do steroids impact survival in patients undergoing immunotherapy for NSCLC?
🫁 Don't miss this insightful interview with @nievamd of @KeckMedicineUSC, who discusses recent bedside-to-bench research that addressed the question.
➡️ Watch: buff.ly/FI2FBsS
#lcsm
Jorge Nieva retweeted
Diving beyond EGFR in NSCLC with an excellent session chaired by @SchenkLab, featuring a stellar lineup of talks on KRAS, BRAF, ROS1, MET, RET, and more!
With insights from @christinemphmd @drgandara @mihaela_aldea @nievamd @riess_md
@OncLive #BTGLung2025 #LCSM #Oncology
Jorge Nieva retweeted
A huge thanks to @nievamd, of @KECKSchool_USC, who stopped by during #BTGLung2025 to talk about the management of ALK rearrangements in NSCLC! Check out our site for exclusive insights from Dr Nieva and more! #lcsm #oncology
onclive.com/bridging-the-gap…
Jorge Nieva retweeted
‼️Polling Q2. Emerging treatment options in SCLC
What do you see as the most promising strategy to improve OS in SCLC?
#BTGLung2025 @sands_jacob @triparnasen @NarjustFlorezMD @DrEdKim @AnaVManana @OncLive
20%ADCs
60%T-cell engagers
7%Novel IO combos
13%Earlier detection
85 votes • Final results Jorge Nieva retweeted
Join OncLive LIVE July 23, 3:30 PM PT. Engage w/ Narjust Florez, MD, Edward S. Kim, MD, Eric K. Singhi, MD & vote in interactive polls! See how your answers align w/ experts. Follow @OncLive & click 🔔 for alerts! #BTGLung2025 @lungoncdoc @DrEdKim @NarjustFlorezMD
Jorge Nieva retweeted
The FDA has approved taletrectinib for ROS1+ NSCLC, but what does that mean for clinical practice? On #LungCancerConsidered, @StephenVLiu, @EnriquetaFelip & @nievamd discuss this approval & how to position taletrectinib among treatment options.
🎧 bit.ly/FDATaletrectinib
Jorge Nieva retweeted
Tune in tomorrow for the latest episode of the @IASLC podcast, Lung Cancer Considered, where I discuss the recent FDA approval of taletrectinib in #ROS1 NSCLC, with Drs. @nievamd and @EnriquetaFelip. Where will this drug fit into the treatment landscape? Download tomorrow!
Jorge Nieva retweeted
We are publishing EGFR resistant tumor data here after profiling more than 45,000 tumors, the documentation of the prevalence of resistance mutations (718,721,797 etc.) is very important however we need to increase awareness to repeat molecular profiling after TKI failure to have more accurate idea of the mechanisms of resistance, thanks to @carisls @DanielSumarriva @StephenVLiu @nievamd @HirvaMamdani @GlopesMd @HosseinBorghaei @HinaKhanMD @MNagasaka Mark Socinsky Tony Wozniak for the collaboration @IASLC @EGFRResisters @EgfrUk @EGFRSummit @egfr @EGFRmNSCLC @DFEGFRcenter @MCIStrong @mhshospital @FLASCO_ORG #lungcancer #lcsm
tandfonline.com/doi/full/10.…
Jorge Nieva retweeted
Dr. @nievamd now presenting #KRAS and #BRAF.
What is signaling? Why do mutations in KRAS and BRAF mess it up?
#TargetedTherapiesInLungCancer #LungCancer
Jorge Nieva retweeted
#Smoking is associated with #KRAS (~100%) and #BRAF (50%) alterations.
• Increases cancers of upper airway, stomach, mouth, tongue, liver, cervix, bladder…
• So: Don’t start smoking
• If you smoke, quit. Your risk of cancer starts coming down about two years.
• Quitting is hard…..so try again!
• Nicotine replacement (gum, patches, or vape) is better than smoking.
Amazing presentation @nievamd!
Jorge Nieva retweeted
My friend @nievamd from @uscnorris is speaking on KRAS & BRAF as part of @cancerGRACE Targeted Therapies Forum, explaining complex science in a remarkably accessible way. Beautiful job in a tough task!
Jorge Nieva retweeted
Dr. @nievamd is Associate Professor of Clinical Medicine at the Keck School of Medicine of the University of Southern California. He is a member of the USC/Norris Comprehensive Cancer Center and Section Head of Thoracic and Head/Neck Tumors. Dr. Nieva is an internationally recognized expert in lung and head/neck cancers as well as biomarker discovery and development. He served as a standing member of the U.S. Food and Drug Administration’s Oncology Drug Advisory Committee (ODAC) from 2021-2024. A recipient of multiple teaching awards for medical education, he has over 100 peer reviewed publications.
If you want to learn more about Dr. Nieva click here: keck.usc.edu/faculty-search/…
To register for our Targeted Therapies in Lung Cancer Forum, click here: live.classy.org/register/ttl…
Jorge Nieva retweeted
Our #lungcancer team at @CancerExpertNow 2025 PRIMO meeting in Hawaii w
@dramycummings @MNagasaka @nievamd #lcsm @mecmededucation
Jorge Nieva retweeted
Recently published:
Real-world Incidence of ALK Alterations in Hispanics with #NSCLC at a Large Academic Institution in Los Angeles, by Darin Poei et al. doi.org/10.1158/2767-9764.CR…
@md_hsu @nievamd @uscnorris @KECKSchool_USC #lungcancer #openaccess
Jorge Nieva retweeted
A dedicated athlete and nonsmoker, Linda Kneidinger's lung cancer diagnosis was unexpected. Learn how our team of experts, including Dr. Graeme Rosenberg and Dr. Jorge Nieva, provided compassionate care for Linda. bit.ly/4fDoAkS
#lungcancer